technetium tc 99m sestamibi has been researched along with cyclosporine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballinger, JR; Boxen, I; Erlichman, C; Ling, V; Sheldon, KM | 1 |
| Ballinger, JR; Tannock, IF; Tunggal, JK | 1 |
| Civi, G; Halaĉ, M; Kabasakal, L; Nisli, C; Oguz, O; Onsel, C; Uslu, I | 1 |
| Balkay, L; Galuska, L; Goda, K; Juhász, I; Krasznai, Z; Márián, T; Mikecz, P; Nagy, H; Szabó, G; Szincsák, N; Trón, L | 1 |
| Balkay, L; Esik, O; Galuska, L; Hernádi, Z; Krasznai, Z; Krasznai, ZT; Márián, T; Szabó, G; Szabó-Péli, J; Trón, L | 1 |
| Hu, Y; Mizoi, K; Naitoh, Y; Sasajima, T; Satoh, T; Shimada, N; Takahashi, M | 1 |
| Ballinger, JR; Cheow, HK; Chilvers, ER; Hartman, NG; Peters, AM; Ruparelia, P; Shankar, S; Szczepura, KR | 1 |
| Fodor, Z; Galuska, L; Goda, K; Hernádi, Z; Krasznai, ZT; Mikecz, P; Szabó, G; Tóth, A | 1 |
| Fernandes, C; Gano, L; Mendes, F; Paulo, A; Santos, I | 1 |
1 trial(s) available for technetium tc 99m sestamibi and cyclosporine
| Article | Year |
|---|---|
Does P-glycoprotein have a role in the lung clearances of inhaled 99mTc-sestamibi and 99mTc-tetrofosmin?
Topics: Administration, Inhalation; Administration, Oral; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Female; Humans; Lung; Male; Metabolic Clearance Rate; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Smoking; Steroids; Technetium Tc 99m Sestamibi | 2009 |
8 other study(ies) available for technetium tc 99m sestamibi and cyclosporine
| Article | Year |
|---|---|
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Cricetinae; Cyclosporine; Down-Regulation; Drug Resistance, Neoplasm; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tumor Cells, Cultured; Verapamil | 1995 |
Influence of cell concentration in limiting the therapeutic benefit of P-glycoprotein reversal agents.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Calcium Channel Blockers; Cell Count; Cell Survival; CHO Cells; Colony-Forming Units Assay; Cricetinae; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 1999 |
The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi.
Topics: Alopecia; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Female; Heart; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver; Male; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2000 |
In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Mice; Mice, SCID; Radioisotope Dilution Technique; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed; Verapamil | 2003 |
Biphasic accumulation kinetics of [99mTc]-hexakis-2-methoxyisobutyl isonitrile in tumour cells and its modulation by lipophilic P-glycoprotein ligands.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cricetinae; Cyclosporine; Drug Resistance, Multiple; Fluorine Radioisotopes; Gluconates; Humans; Intracellular Membranes; Ligands; Membrane Fluidity; Membrane Potentials; Mice; Mitochondria; Permeability; Rhodamine 123; Technetium Tc 99m Sestamibi; Verapamil | 2005 |
(99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Brain Neoplasms; Carcinoma 256, Walker; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Cyclosporins; Cytotoxins; Drug Resistance, Neoplasm; Drug Synergism; Predictive Value of Tests; Quinolines; Radiopharmaceuticals; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vincristine | 2007 |
Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ovarian Neoplasms; Paclitaxel; Protein Binding; Rhodamine 123; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2010 |
Studies of the myocardial uptake and excretion mechanisms of a novel 99mTc heart perfusion agent.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Enzyme Inhibitors; In Vitro Techniques; Liver; Male; Metabolic Clearance Rate; Mitochondria; Myocardium; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Technetium Tc 99m Sestamibi; Tissue Distribution | 2012 |